// App-Quantinova.ai

FRI0425 : SIMILAR LEVELS OF DISEASE ACTIVITY IN PATIENTS WITH OLIGOARTICULAR VS. POLYARTICULAR PERIPHERAL SPONDYLOARTHRITIS

Researchers

Presenter

  • F. Van Den Bosch

Principal Investigators

  • P. Mease

  • D. van der Heijde

  • M. Rudwaleit

  • A. L. Pangan

Medical Centers

  • Ghent University Hospital, Ghent, Belgium

  • Leiden University Medical Centre, Leiden, Netherlands

  • Endokrinologikum Berlin, Berlin, Germany

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

Locations

  • United States

  • Germany

  • Belgium

  • Netherlands

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Peripheral spondyloarthritis

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Spondyloarthritis

  • Dactylitis

  • Inflammatory Arthritis

  • Psoriasis

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved